CN110824177B - Rapid detection test paper and preparation method and application thereof - Google Patents
Rapid detection test paper and preparation method and application thereof Download PDFInfo
- Publication number
- CN110824177B CN110824177B CN201910859373.7A CN201910859373A CN110824177B CN 110824177 B CN110824177 B CN 110824177B CN 201910859373 A CN201910859373 A CN 201910859373A CN 110824177 B CN110824177 B CN 110824177B
- Authority
- CN
- China
- Prior art keywords
- microspheres
- pad
- conjugate
- test strip
- membrane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 84
- 238000012360 testing method Methods 0.000 title claims abstract description 39
- 238000002360 preparation method Methods 0.000 title claims abstract description 30
- 239000012528 membrane Substances 0.000 claims abstract description 75
- 102000036639 antigens Human genes 0.000 claims abstract description 14
- 108091007433 antigens Proteins 0.000 claims abstract description 14
- 239000000427 antigen Substances 0.000 claims abstract description 13
- 229940079593 drug Drugs 0.000 claims abstract description 10
- 239000003814 drug Substances 0.000 claims abstract description 10
- 239000004005 microsphere Substances 0.000 claims description 188
- 238000003908 quality control method Methods 0.000 claims description 50
- 230000027455 binding Effects 0.000 claims description 24
- 229920001220 nitrocellulos Polymers 0.000 claims description 19
- 239000000020 Nitrocellulose Substances 0.000 claims description 18
- 239000011230 binding agent Substances 0.000 claims description 12
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 11
- 241000283707 Capra Species 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 10
- 239000003365 glass fiber Substances 0.000 claims description 9
- 238000010521 absorption reaction Methods 0.000 claims description 8
- 239000003086 colorant Substances 0.000 claims description 8
- 238000009597 pregnancy test Methods 0.000 claims description 7
- 239000002245 particle Substances 0.000 claims description 5
- 239000004793 Polystyrene Substances 0.000 claims description 3
- 229940127121 immunoconjugate Drugs 0.000 claims description 3
- 229920002223 polystyrene Polymers 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- 238000004587 chromatography analysis Methods 0.000 claims description 2
- 238000004811 liquid chromatography Methods 0.000 claims description 2
- 229920006267 polyester film Polymers 0.000 claims description 2
- 230000035935 pregnancy Effects 0.000 abstract description 5
- 239000002244 precipitate Substances 0.000 description 48
- 239000000243 solution Substances 0.000 description 44
- 239000006228 supernatant Substances 0.000 description 32
- 239000011535 reaction buffer Substances 0.000 description 30
- 238000009210 therapy by ultrasound Methods 0.000 description 26
- 238000007664 blowing Methods 0.000 description 22
- 230000010355 oscillation Effects 0.000 description 22
- 238000006243 chemical reaction Methods 0.000 description 20
- 239000011248 coating agent Substances 0.000 description 20
- 238000000576 coating method Methods 0.000 description 20
- 238000003756 stirring Methods 0.000 description 20
- 239000000047 product Substances 0.000 description 17
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 16
- 239000003153 chemical reaction reagent Substances 0.000 description 14
- ZPUCINDJVBIVPJ-LJISPDSOSA-N ***e Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 14
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 14
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 12
- 238000004140 cleaning Methods 0.000 description 12
- 108010044467 Isoenzymes Proteins 0.000 description 11
- 239000007788 liquid Substances 0.000 description 11
- 239000000203 mixture Substances 0.000 description 11
- 102000004420 Creatine Kinase Human genes 0.000 description 10
- 108010042126 Creatine kinase Proteins 0.000 description 10
- 102000036675 Myoglobin Human genes 0.000 description 10
- 108010062374 Myoglobin Proteins 0.000 description 10
- 102100036859 Troponin I, cardiac muscle Human genes 0.000 description 10
- 101710128251 Troponin I, cardiac muscle Proteins 0.000 description 10
- 239000003085 diluting agent Substances 0.000 description 10
- 239000012491 analyte Substances 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 230000000903 blocking effect Effects 0.000 description 8
- 238000005119 centrifugation Methods 0.000 description 8
- 238000011161 development Methods 0.000 description 8
- 229960001252 methamphetamine Drugs 0.000 description 8
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 8
- 238000005507 spraying Methods 0.000 description 8
- 239000012089 stop solution Substances 0.000 description 8
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 7
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 7
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 7
- 229960003920 ***e Drugs 0.000 description 7
- 229960005181 morphine Drugs 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 230000000007 visual effect Effects 0.000 description 7
- 102000011022 Chorionic Gonadotropin Human genes 0.000 description 6
- 108010062540 Chorionic Gonadotropin Proteins 0.000 description 6
- 230000002159 abnormal effect Effects 0.000 description 6
- 239000002390 adhesive tape Substances 0.000 description 6
- 238000010009 beating Methods 0.000 description 6
- 230000008878 coupling Effects 0.000 description 6
- 238000010168 coupling process Methods 0.000 description 6
- 238000005859 coupling reaction Methods 0.000 description 6
- 229940084986 human chorionic gonadotropin Drugs 0.000 description 6
- 238000012123 point-of-care testing Methods 0.000 description 6
- 230000001376 precipitating effect Effects 0.000 description 6
- 238000004321 preservation Methods 0.000 description 6
- KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical compound C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 description 5
- 229940025084 amphetamine Drugs 0.000 description 5
- 238000007865 diluting Methods 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 239000007790 solid phase Substances 0.000 description 5
- 238000003260 vortexing Methods 0.000 description 5
- 241000218236 Cannabis Species 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 238000002372 labelling Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- 230000001360 synchronised effect Effects 0.000 description 4
- 101100512901 Caenorhabditis elegans mes-4 gene Proteins 0.000 description 3
- 244000025254 Cannabis sativa Species 0.000 description 3
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 3
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 3
- 101100512902 Drosophila melanogaster Mes-4 gene Proteins 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 229920001213 Polysorbate 20 Polymers 0.000 description 3
- 239000007983 Tris buffer Substances 0.000 description 3
- 238000004220 aggregation Methods 0.000 description 3
- 230000002776 aggregation Effects 0.000 description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- 235000009120 camo Nutrition 0.000 description 3
- 235000005607 chanvre indien Nutrition 0.000 description 3
- 238000005520 cutting process Methods 0.000 description 3
- 239000011888 foil Substances 0.000 description 3
- 239000011487 hemp Substances 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 3
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- 238000002604 ultrasonography Methods 0.000 description 3
- 238000011179 visual inspection Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 102100025036 Norrin Human genes 0.000 description 2
- 101710085992 Norrin Proteins 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 239000013504 Triton X-100 Substances 0.000 description 2
- 229920004890 Triton X-100 Polymers 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000003255 drug test Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000009871 nonspecific binding Effects 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 238000002203 pretreatment Methods 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 238000006748 scratching Methods 0.000 description 2
- 230000002393 scratching effect Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 102000013394 Troponin I Human genes 0.000 description 1
- 108010065729 Troponin I Proteins 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- -1 amphetamines Chemical compound 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000007767 bonding agent Substances 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- UQGFMSUEHSUPRD-UHFFFAOYSA-N disodium;3,7-dioxido-2,4,6,8,9-pentaoxa-1,3,5,7-tetraborabicyclo[3.3.1]nonane Chemical compound [Na+].[Na+].O1B([O-])OB2OB([O-])OB1O2 UQGFMSUEHSUPRD-UHFFFAOYSA-N 0.000 description 1
- 239000003596 drug target Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910002804 graphite Inorganic materials 0.000 description 1
- 239000010439 graphite Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 238000010532 solid phase synthesis reaction Methods 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/948—Sedatives, e.g. cannabinoids, barbiturates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Endocrinology (AREA)
- Anesthesiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Reproductive Health (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Test | Detection line | 5 | |
Negative urine | No color development | Blue color | |
Negative serum | No color development | Blue color | |
Negative plasma | No color development | Blue color | |
Negative whole blood | No color development | Blue color | |
Human chorionic gonadotropin 10mIU/mL | Red colour | Blue color | |
Human chorionic gonadotropin 100mIU/mL | Red colour | Blue color | |
Human chorionic gonadotropin 1IU/mL | Red colour | Blue color | |
Human chorionic gonadotropin 2IU/mL | Red colour | Blue color | |
Human chorionic gonadotropin 10IU/mL | Red colour | Blue color | |
Human chorionic gonadotropin 20IU/mL | Red colour | Blue color |
Material numbering | Cardiac troponin I | Creatine kinase isoenzyme | Myoglobin | |
Baseboard (1) | 1 | 1 | 1 | |
Chromatographic carrier (2) | 2 | 2 | 2 | |
Detection line (5) | | 5b | 5c | |
Quality control line (6) | 6 | 6 | 6 | |
Chromatographic carrier (2) fixed hole (8) | 8 | 8 | 8 | |
Combined cushion (3) | 3 | 3 | 3 | |
Detection line conjugate (4-1) | 4-1a | 4-1b | 4-1c | |
Quality control line conjugate (4-2) | 4-2 | 4-2 | 4-2 | |
Single-sided tape (11) | / | / | / | |
Combined pad (3) fixed hole (7) | 7 | 7 | 7 | |
Sample adding pad (9) | / | / | / | |
Suction pad (10) | / | / | / | |
Card case (12) | 12-1 box type card | 12-1 box type card | 12-1 box type card |
Material number | Early pregnancy test paper |
Baseboard (1) | 1 |
Chromatographic carrier (2) | 2 |
Detection line (5) | 5 |
Quality control line (6) | 6 |
Chromatographic carrier (2) fixed hole (8) | / |
Combined cushion (3) | 3 |
Detection line conjugate (4-1) | 4-1 |
Quality control line conjugate (4-2) | 4-2 |
Single-sided tape (11) | 11 |
Combined cushion fixed hole (7) | / |
Sample adding pad (9) | 9 |
Suction pad (10) | 10 |
Card case (12) | / |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910859373.7A CN110824177B (en) | 2019-09-11 | 2019-09-11 | Rapid detection test paper and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910859373.7A CN110824177B (en) | 2019-09-11 | 2019-09-11 | Rapid detection test paper and preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110824177A CN110824177A (en) | 2020-02-21 |
CN110824177B true CN110824177B (en) | 2021-06-11 |
Family
ID=69547980
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910859373.7A Active CN110824177B (en) | 2019-09-11 | 2019-09-11 | Rapid detection test paper and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110824177B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111157749B (en) * | 2020-01-13 | 2021-06-22 | 润和生物医药科技(汕头)有限公司 | Rapid detection test paper and preparation method and application thereof |
CN111579782B (en) * | 2020-05-25 | 2023-10-10 | 山西瑞豪生物科技有限公司 | Biomedical detection method for intelligent fluorescent multi-marker |
CN111638327B (en) * | 2020-07-01 | 2023-10-13 | 成都赛普克生物科技股份有限公司 | Treatment fluid and treatment method for colloidal gold immunochromatographic test paper gold-labeled pad and sample pad |
CN112698042A (en) * | 2020-12-17 | 2021-04-23 | 北京赛诺浦生物技术有限公司 | Fluorescent immunochromatography test strip for detecting human growth differentiation factor-15 and preparation method and application thereof |
CN112986567A (en) * | 2021-01-27 | 2021-06-18 | 佛山微侦警用科技有限公司 | Reagent component ratio and preparation method of multi-project rapid quantitative drug detection box |
CN114236119A (en) * | 2021-11-08 | 2022-03-25 | 润和生物医药科技(汕头)有限公司 | Colloidal gold rapid detection test paper for new crown total antibody and neutralizing antibody and preparation method thereof |
Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU614294B2 (en) * | 1987-07-13 | 1991-08-29 | Abbott Laboratories | Process for immunochromatography with colloidal particles |
JP2003513244A (en) * | 1999-10-27 | 2003-04-08 | ジェノシス リミテッド | Lateral flow devices utilizing particulate carriers |
CN1580778A (en) * | 2004-05-21 | 2005-02-16 | 王继华 | Colour latex chromato graphic analysis diagnositc test paper tape and its preparing method |
EP1826566A1 (en) * | 2005-01-12 | 2007-08-29 | Sysmex Corporation | Immunochromatographic test device |
CN102565388A (en) * | 2012-01-16 | 2012-07-11 | 宁波天润生物药业有限公司 | Widal test card |
CN102928600A (en) * | 2012-11-07 | 2013-02-13 | 深圳市宝凯仑科技有限公司 | Method for preparing fast detecting test paper of illegal cooking oil |
CN104076142A (en) * | 2014-03-05 | 2014-10-01 | 广东医学院附属医院 | Fluorescent microsphere lateral chromatographic detection strip for multiple joint inspection of trace target substances as well as preparation method and application thereof |
CN104991067A (en) * | 2014-08-20 | 2015-10-21 | 苏州和锐医药科技有限公司 | Preparation method and applications of anti-ASCA antibody test paper |
CN105137066A (en) * | 2015-07-31 | 2015-12-09 | 江苏巨珩新材料科技有限公司 | Polystyrene latex based cancer marker immuno-chromatography kit and application method thereof |
CN205333649U (en) * | 2016-01-21 | 2016-06-22 | 成都微瑞生物科技有限公司 | Pig circovirus antibody test card |
CN106290838A (en) * | 2015-05-13 | 2017-01-04 | 上海凯创生物技术有限公司 | A kind of dengue virus IgG/IgM antibody emulsion technique detection kit |
CN107328926A (en) * | 2017-06-29 | 2017-11-07 | 海格德生物科技(深圳)有限公司 | Reagent card, preparation method and the detection method of the multinomial heart failure mark of quick detection |
CN108267592A (en) * | 2017-01-03 | 2018-07-10 | 普迈德(北京)科技有限公司 | A kind of immune microsphere chromatography detects heparin-binding protein Test paper |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7390674B2 (en) * | 2005-03-14 | 2008-06-24 | Kimberly-Clark Worldwide, Inc. | Lateral flow devices using reactive chemistry |
-
2019
- 2019-09-11 CN CN201910859373.7A patent/CN110824177B/en active Active
Patent Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU614294B2 (en) * | 1987-07-13 | 1991-08-29 | Abbott Laboratories | Process for immunochromatography with colloidal particles |
JP2003513244A (en) * | 1999-10-27 | 2003-04-08 | ジェノシス リミテッド | Lateral flow devices utilizing particulate carriers |
CN1580778A (en) * | 2004-05-21 | 2005-02-16 | 王继华 | Colour latex chromato graphic analysis diagnositc test paper tape and its preparing method |
EP1826566A1 (en) * | 2005-01-12 | 2007-08-29 | Sysmex Corporation | Immunochromatographic test device |
CN102565388A (en) * | 2012-01-16 | 2012-07-11 | 宁波天润生物药业有限公司 | Widal test card |
CN102928600A (en) * | 2012-11-07 | 2013-02-13 | 深圳市宝凯仑科技有限公司 | Method for preparing fast detecting test paper of illegal cooking oil |
CN104076142A (en) * | 2014-03-05 | 2014-10-01 | 广东医学院附属医院 | Fluorescent microsphere lateral chromatographic detection strip for multiple joint inspection of trace target substances as well as preparation method and application thereof |
CN104991067A (en) * | 2014-08-20 | 2015-10-21 | 苏州和锐医药科技有限公司 | Preparation method and applications of anti-ASCA antibody test paper |
CN106290838A (en) * | 2015-05-13 | 2017-01-04 | 上海凯创生物技术有限公司 | A kind of dengue virus IgG/IgM antibody emulsion technique detection kit |
CN105137066A (en) * | 2015-07-31 | 2015-12-09 | 江苏巨珩新材料科技有限公司 | Polystyrene latex based cancer marker immuno-chromatography kit and application method thereof |
CN205333649U (en) * | 2016-01-21 | 2016-06-22 | 成都微瑞生物科技有限公司 | Pig circovirus antibody test card |
CN108267592A (en) * | 2017-01-03 | 2018-07-10 | 普迈德(北京)科技有限公司 | A kind of immune microsphere chromatography detects heparin-binding protein Test paper |
CN107328926A (en) * | 2017-06-29 | 2017-11-07 | 海格德生物科技(深圳)有限公司 | Reagent card, preparation method and the detection method of the multinomial heart failure mark of quick detection |
Also Published As
Publication number | Publication date |
---|---|
CN110824177A (en) | 2020-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110824177B (en) | Rapid detection test paper and preparation method and application thereof | |
KR101540608B1 (en) | Assay strip having variable control line, and diagnosis kit using the same | |
JP2638600B2 (en) | Immunodiagnosis device | |
KR101947884B1 (en) | Immunochromatographic assay method | |
JPH01503174A (en) | Test method | |
JP2006215017A (en) | Device for discontinuous immunoassay and method of immunoassay utilizing it | |
JPH04506117A (en) | Biological assay device and assay method using it | |
JP4800739B2 (en) | Assay medium and assay method | |
US11619630B2 (en) | Immunochromatography device | |
WO2002037108A1 (en) | Reagent and method for detecting substance | |
JP2008268043A (en) | Method for forming detection part of examination device, and examination device for measuring lateral flow immunity | |
EP1197754A1 (en) | Methods and device for detecting prostate specific antigen (PSA) | |
CN106526166A (en) | Rapid detection of lean meat powder in pork | |
JP2002148266A (en) | Detector and its manufacturing method | |
CN111157749B (en) | Rapid detection test paper and preparation method and application thereof | |
JP4365329B2 (en) | Simple assay device and method for detecting a plurality of objects to be detected | |
CN102388312B (en) | Analysis method, sample analyzing tool, method of preventing backflow of sample solution and method of preventing background rise | |
JP3841559B2 (en) | Immunological examination method and immunological examination kit | |
WO2008086845A1 (en) | Lateral-flow test device providing improved test quality | |
EP3885767B1 (en) | Test piece for immunochromatography and immunochromatographic detection kit | |
JP2001305139A (en) | Specific bond body | |
JP2000028612A (en) | Immunological inspection method and immunological inspection kit thereof | |
CN215415460U (en) | Rapid detection test strip and rapid detection card | |
CN114113615B (en) | Immunochromatography detection test strip for screening universal monoclonal antibodies and detection method | |
JP2002328130A (en) | Testing piece for immunological measurement method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder |
Address after: Room 116, Floor 1, Transportation Bureau Building, No. 95, Yingbin Avenue, Huacheng Street, Huadu District, Guangzhou, Guangdong Province, 510801 Patentee after: Guangzhou Iconas Biomedical Technology Co.,Ltd. Address before: Room 116, Floor 1, Transportation Bureau Building, No. 95, Yingbin Avenue, Huacheng Street, Huadu District, Guangzhou, Guangdong Province, 510801 Patentee before: Guangzhou Iconas Biomedical Technology Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
CP03 | Change of name, title or address |
Address after: Room 116, Floor 1, Transportation Bureau Building, No. 95, Yingbin Avenue, Huacheng Street, Huadu District, Guangzhou, Guangdong Province, 510801 Patentee after: Guangzhou Iconas Biomedical Technology Co.,Ltd. Address before: 515063 in Rongsheng science and Technology Park, University Road, Shantou City, Guangdong Province Patentee before: RUNBIO BIOTECH Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
CI03 | Correction of invention patent |
Correction item: Patentee|Address Correct: RUNBIO BIOTECH Co.,Ltd.|515063 in Rongsheng science and Technology Park, University Road, Shantou City, Guangdong Province False: Guangzhou Iconas Biomedical Technology Co.,Ltd.|Room 116, Floor 1, Transportation Bureau Building, No. 95, Yingbin Avenue, Huacheng Street, Huadu District, Guangzhou, Guangdong Province, 510801 Number: 10-02 Volume: 39 |
|
CI03 | Correction of invention patent | ||
CP01 | Change in the name or title of a patent holder |
Address after: Room 116, Floor 1, Transportation Bureau Building, No. 95, Yingbin Avenue, Huacheng Street, Huadu District, Guangzhou, Guangdong Province, 510801 Patentee after: Guangdong Iconas Biomedical Technology Co.,Ltd. Address before: Room 116, Floor 1, Transportation Bureau Building, No. 95, Yingbin Avenue, Huacheng Street, Huadu District, Guangzhou, Guangdong Province, 510801 Patentee before: Guangdong Iconas Biomedical Technology Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
CP03 | Change of name, title or address |
Address after: Room 116, Floor 1, Transportation Bureau Building, No. 95, Yingbin Avenue, Huacheng Street, Huadu District, Guangzhou, Guangdong Province, 510801 Patentee after: Guangdong Iconas Biomedical Technology Co.,Ltd. Address before: 515063 in Rongsheng science and Technology Park, University Road, Shantou City, Guangdong Province Patentee before: RUNBIO BIOTECH Co.,Ltd. |
|
CP03 | Change of name, title or address |